Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Return on Sales: 2015-2020

Historic Return on Sales for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2020 value amounting to 21.82%.

  • Outlook Therapeutics' Return on Sales rose 2606.00% to 21.82% in Q3 2020 from the same period last year, while for Sep 2020 it was 21.82%, marking a year-over-year increase of 2606.00%. This contributed to the annual value of 23.87% for FY2024, which is 57.00% up from last year.
  • Per Outlook Therapeutics' latest filing, its Return on Sales stood at 21.82% for Q3 2020, which was up 333.28% from -9.35% recorded in Q2 2020.
  • Over the past 5 years, Outlook Therapeutics' Return on Sales peaked at 21.82% during Q3 2020, and registered a low of -37.62% during Q1 2017.
  • For the 3-year period, Outlook Therapeutics' Return on Sales averaged around -5.38%, with its median value being -7.76% (2020).
  • As far as peak fluctuations go, Outlook Therapeutics' Return on Sales tumbled by 2,434bps in 2017, and later skyrocketed by 3,316bps in 2018.
  • Over the past 5 years, Outlook Therapeutics' Return on Sales (Quarterly) stood at -24.27% in 2016, then surged by 1,921bps to -5.06% in 2017, then crashed by 614bps to -11.21% in 2018, then spiked by 603bps to -5.18% in 2019, then skyrocketed by 2,606bps to 21.82% in 2020.
  • Its Return on Sales was 21.82% in Q3 2020, compared to -9.35% in Q2 2020 and -7.76% in Q1 2020.